Literature DB >> 3211498

Surgical therapy of chronic glaucoma in aphakia and pseudophakia.

R L Gross1, R M Feldman, G L Spaeth, W C Steinmann, D Spiegel, L J Katz, R P Wilson, R Varma, M R Moster, S Marks.   

Abstract

Most glaucoma surgical procedures are less successful in aphakic or pseudophakic eyes. The authors reviewed 91 consecutive initial glaucoma procedures in aphakic patients from 1979 to 1986 to determine successful outcomes and complications. Success was defined as an intraocular pressure (IOP) of at least 30% below the preoperative value and less than 21 mmHg, less than 2 lines of Snellen acuity loss, and no further surgical intervention. At 9 months, success rates were: trabeculectomy, 4 of 15 patients; cyclodialysis, 3 of 20 patients; neodymium:YAG (Nd:YAG) cyclophotocoagulation, 1 of 8 patients; cyclocryotherapy, 9 of 22 patients; anterior chamber tube shunt (Schocket procedure), 3 of 6 patients; and argon laser trabeculoplasty, 2 of 20 patients. Severe complications included phthisis bulbi in 11% of cyclocryotherapy and severe visual loss in 20% with cyclodialysis and 14% with cyclocryotherapy. Results confirm the difficulty of surgical therapy in these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3211498     DOI: 10.1016/s0161-6420(88)33027-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Coexistent corneal disease and glaucoma managed by either drainage surgery and subsequent keratoplasty or combined drainage surgery and penetrating keratoplasty.

Authors:  C M Kirkness; A D Steele; L A Ficker; N S Rice
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

2.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Trabeculectomy with anterior vitrectomy in aphakic and pseudophakic glaucoma.

Authors:  S Melamed; D Neumann; M Blumenthal
Journal:  Int Ophthalmol       Date:  1991-05       Impact factor: 2.031

4.  Risk factors for failures of trabeculectomies performed without antimetabolites.

Authors:  H Mietz; B Raschka; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

5.  A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.

Authors:  D P S O'Brart; M Shiew; B Edmunds
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

6.  Restricted post-trabeculectomy bleb formation by conjunctival scarring.

Authors:  Keiichiro Iwao; Masaru Inatani; Minako Ogata-Iwao; Yuji Takihara; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-12       Impact factor: 3.117

7.  A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy.

Authors:  D P S O'Brart; E Rowlands; N Islam; A M S Noury
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

8.  Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture.

Authors:  I A Cunliffe; P S Richardson; R C Rees; I G Rennie
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

9.  Comparing Treatment Outcomes from the Tube Versus Trabeculectomy and Primary Tube Versus Trabeculectomy Studies.

Authors:  Steven J Gedde; William J Feuer; Philip P Chen; Dale K Heuer; Kuldev Singh; Martha M Wright
Journal:  Ophthalmology       Date:  2020-07-02       Impact factor: 14.277

10.  Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.

Authors:  Masoumeh B Masoumpour; M Hossein Nowroozzadeh; M Reza Razeghinejad
Journal:  Open Ophthalmol J       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.